Weight Symptoms and Causes

Birth Weight is the first Weight of your baby, taken just after he or she is born. A low birth Weight is less than 5.5 pounds. A high birth Weight is more than 8.8 pounds.

A low birth Weight baby can be born too small, too early (premature), or both. This can happen for many different reasons. They include health problems in the mother, genetic factors, problems with the placenta and substance abuse by the mother.

Some low birth Weight babies may be more at risk for certain health problems. Some may become sick in the first days of life or develop infections. Others may suffer from longer-term problems such as delayed motor and social development or learning disabilities.

High birth Weight babies are often big because the parents are big, or the mother has diabetes during pregnancy. These babies may be at a higher risk of birth injuries and problems with blood sugar.

Centers for Disease Control and Prevention

Check out the latest treatments for weight

weight treatment research studies

Phentermine clinical trials, surveys and public health registries

Find Drug Side Effect reports



Phentermine Side Effects

Pain (28)
Dyspnoea (27)
Anxiety (26)
Chest Pain (22)
Deep Vein Thrombosis (20)
Nausea (19)
Abdominal Pain (18)
Headache (16)
Blood Pressure Increased (16)
Abdominal Pain Upper (16)
Mitral Valve Incompetence (15)
Cholelithiasis (15)
Cholecystitis Chronic (14)
Pulmonary Embolism (14)
Injury (13)
Vomiting (13)
Ventricular Fibrillation (13)
Myocardial Infarction (13)
Loss Of Consciousness (12)
Dizziness (12)
Colitis Ischaemic (11)
Cardiac Arrest (11)
Gallbladder Disorder (10)
Fatigue (10)
Insomnia (10)
Cerebrovascular Accident (9)
Hypertension (9)
Arteriospasm Coronary (9)
Palpitations (8)
Confusional State (8)
Chest Discomfort (7)
Convulsion (7)
Hypotension (7)
Emotional Distress (7)
Feeling Abnormal (7)
Asthenia (6)
Abnormal Behaviour (6)
Diarrhoea (6)
Pain In Extremity (6)
Hypoaesthesia (6)
Tricuspid Valve Incompetence (6)
Hypercoagulation (5)
Alanine Aminotransferase Increased (5)
Mental Disorder (5)
Heart Rate Increased (5)
Pneumomediastinum (5)
Ventricular Tachycardia (5)
Respiratory Arrest (5)
Pyrexia (5)
Migraine (5)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

After becoming very ill, suffering much pain, losing weight and having many sleepless nights i was finally diagnosed with hoshimotos disease, subsequently i have hypothyroidism. I am only talking 50 mg oroxine 3 times a week and 100 mg the other 2 d

Fluvoxamine put weight on

IF I AM 180 POUNDS AND IM ABOUT 5'0 I AM CLINICALLY OBESE TECHNICALLY SO WOULD I BE ABLE TO GET A SURGERY BECAUSE FOR MY FRAME IM SUPPOSE TO BE 104. THAT WOULD PUT ME AT ABOUT 80 POUNDS OVERWEIGHT RIGHT?

Lost about half of my hair, weight loss and continued brain fog even 5 years later

Seroquel weight increase of up to 10 pounds in the first month, sleep paralysis Halperidol (haldol) weight increase, dizziness, shaking, seizures

Weight gain of 25 lbs. Normally weigh 120. Os tjos possible

<b><span style='font-weight: normal;'><b>After 6 weeks of oral lamisil I experienced</b>eczema, muscle weakness, asthma, bloody bowels, lower abdominal pain, dizziness, extreme f

I have just come back from a funeral for my brother. He was just 62. He was on statin medicine but his cholestrol, blood pressure, weight and diet was very much in control. In fact just a day before his death the doctor told him that he was doing f

Has anyone gained weight from taking xyzal? It has helped my alergies but I've gained 12 lbs.....

I don't know. I have been taking Lithium for my Bi-Polar for three years now, and besides the weight gain, I have been doing well! My Doctor wants me to try Zeldox, what should I do?

I have experienced weight loss of a pound a month for the last 2 years, since taking 100 mcg per day. My dr. can find no cause for this loss. I also have taken Metformin for about the same amount of time.

On 4/25/2006, I took the first of the three Hepatitis B shots. I suddenly had flu like symptoms which lasted for ever. I started getting really weak. I would eventually start losing weight. I went from 269 down to 118. I was diagnosed with Dermatomy

I am 23 years old, and after the bith of my daughter this year I discovered the I had a very underactive Thyroid. My doctor diagnosed me, and put me on 50 micrograms of Levothyroxine to regulate my levels and help me take off the weight tha

I am Aged 46, and have been On Kliovance for 6 weeks, have gained weight, bloated stomach, extreme tiredness,aching bones, restlessness...,edgy...The sweats have gone but thats all.I find there is not enough relevant information for women f

i losing weight doctor say i might have bonchitis

Weight Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
RankStatusStudy
1 Recruiting Weight Loss Study-Mechanism Underlying the Improvement of Insulin Resistance in Response to Weight Loss
Conditions: Obesity;   Weight Loss
Intervention: Dietary Supplement: Weight loss group (Full meal replacement products)
Outcome Measures: The primary outcome will be the difference in insulin and leptin tolerance after Weight loss;   Difference in brain signaling before and after the 10 ~+mn~ 2% body Weight reduction.
2 Recruiting PILI at Work a 5-Year Controlled Intervention Trial: Testing DVD Versus Group Delivery of a Weight-Loss Maintenance Intervention in Native Hawaiian- Serving Worksites
Conditions: Obesity;   OverWeight;   Weight Loss;   Weight Loss Maintenance
Interventions: Behavioral: Weight loss maintenance intervention face-to-face;   Behavioral: Weight loss maintenance intervention delivered via DVD
Outcome Measures: Change in Weight from baseline to 3-month and 12-month follow up;   Change in physical functioning from baseline to 3-month and 12-month follow up;   Blood pressure;   Physical Activity Frequency;   Fat in Diet
3 Not yet recruiting Internet-Based Weight-Loss Program for Colorectal Cancer Survivors
Conditions: Cancer Survivor;   Colorectal Cancer;   Weight Changes
Intervention: Behavioral: Internet Weight loss intervention
Outcome Measures: Feasibility of implementing an Internet-based Weight-loss intervention for colorectal cancer survivors;   Impact of an Internet-based intervention on Weight loss;   Impact of an Internet-based intervention on waist circumference, physical activity, diet, Weight-control strategies, Weight-loss intention, exercise and diet self-efficacy, and perceived Weight-loss barriers;   Potential moderators of Weight loss
4 Recruiting Healthy Living After Cancer: Weight Management Pilot Study
Condition: Weight Loss Program After Cancer Diagnosis
Interventions: Behavioral: Immediate Weight Loss Program Group;   Behavioral: Delayed Weight Loss Program Group
Outcome Measures: To evaluate the impact of a 16-week, group-based Weight loss intervention upon body Weight in a group of cancer survivors.;   To evaluate the impact of a 16-week Weight loss intervention upon the following in a group of cancer survivors.
5 Recruiting Body Weight and Vascular Function
Conditions: Metabolic Syndrome;   Obesity
Interventions: Other: Weight-loss treatment;   Other: No-Weight loss treatment
Outcome Measures: Vascular activity: differences between lean and abdominally overWeight / obese men and effects of Weight loss;   Vascular function markers related to the macrovasculature: differences between lean and abdominally overWeight / obese men and effects of Weight loss;   Vascular function markers related to the microvasculature: differences between lean and abdominally overWeight / obese men and effects of Weight loss;   Metabolic risk markers related to the metabolic syndrome: differences between lean and abdominally overWeight / obese men and effects of Weight loss
6 Recruiting Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
Conditions: Obesity;   Weight Loss
Interventions: Behavioral: Behavioral Weight Loss Treatment;   Procedure: Transcranial Direct Current Stimulation (TDCS);   Device: Transcranial Direct Current Stimulation (TDCS);   Behavioral: Appetite Control;   Procedure: Appetite Control;   Device: Weight Control;   Behavioral: Weight Loss
Outcome Measures: Effects of TCDS on Weight loss and appetite.;   Effect of behavioral intervention on Weight loss.
7 Unknown Weight Gain During Pregnancy - a Randomized Controlled Trial of Intervention to Prevent Excessive Gestational Weight Gain
Condition: Weight Gain
Intervention: Behavioral: motivational intervention in pregnancy
Outcome Measures: The number of women with a Weight gain during pregnancy within IOM´s recommendation is compared between study groups.;   Weight retention(kg) up until one year after delivery is compared between study groups.;   Number of fetal and maternal complications in pregnancy is compared between study groups;   Number of fetal and maternal complications during delivery is compared between study groups;   Child birth Weight and Weight development of the child up to one year of age is compared between study groups.
8 Unknown Pregnancy Outcomes in OverWeight Women With Prior Miscarriages Following a Structured Weight Loss Program Versus Weight-Loss Counseling
Conditions: Obese;   OverWeight;   Miscarriage;   Recurrent Pregnancy Loss
Interventions: Behavioral: Structured Weight Loss Program;   Behavioral: Routine Weight Loss Counseling
Outcome Measures: Term live birth rate;   Weight loss - goal for Weight loss defined as 5 percent of enrollment body Weight lost;   Changes in triglyceride levels;   Changes in high density lipoprotein levels;   Changes in alanine aminotransferase (ALT) levels;   Changes in fasting insulin levels;   Changes in postprandial insulin levels;   Changes in fasting glucose levels;   Changes in postprandial glucose levels;   Changes in hemoglobin A1c levels
9 Recruiting Behavioral Weight Loss and Exercise After Treatment (BEAT)
Condition: Breast Cancer
Intervention: Behavioral: 12 month exercise and Weight loss intervention
Outcome Measures: Correlation of executive function and Weight loss success;   Correlation of cancer related symptoms and Weight loss;   Efficacy of a Weight loss intervention
10 Recruiting Sleep Plus Eating Routines for Weight Loss
Condition: OverWeight and Obesity
Interventions: Behavioral: Weight Loss Education;   Behavioral: Sleep and Eating Routine
Outcome Measures: Weight;   Executive Control
11 Recruiting An Adipocyte-Driven Mechanism For Weight Regain After Weight Loss: The Yo-Yo Effect
Conditions: Obesity;   Weight Loss;   Diet
Interventions: Other: Meal replacement diet using Modifast;   Other: Normal diet combined with Modifast diet
Outcome Measures: change in Weight following Weight loss;   change in adipokine profile due to dietary intervention (VLCD-group);   change in adipokine during Weight stable-period (VLCD-group);   change in adipokine profile during follow-up (VLCD-group);   change in adipokine profile due to dietary intervention (LCD-group);   change in adipokine profile during Weight-stable period (LCD-group);   change in adipokine profile during follow-up (LCD-group);   change in parameters of adipocyte fat metabolism due to dietary intervention (VLCD-group);   change in parameters of adipocyte fat metabolism during Weight-stable period (VLCD-group);   change in parameters of adipocyte fat metabolism during follow-up period (VLCD-group);   change in parameters of adipocyte fat metabolism due to dietary intervention (LCD-group);   change in parameters of adipocyte fat metabolism during Weight-stable period (LCD-group);   change in parameters of adipocyte fat metabolism during follow-up (LCD-group);   change in in-vivo adipose tissue metabolism due to dietary intervention (VLCD-group);   change in in-vivo adipose tissue metabolism during Weight-stable period (VLCD-group);   change in in-vivo adipose tissue metabolism during follow-up period (VLCD-group);   change in in-vivo adipose tissue metabolism due to dietary intervention (LCD-group);   change in in-vivo adipose tissue metabolism during Weight-stable period (LCD-group);   change in in-vivo adipose tissue metabolism during follow-up period (LCD-group);   change in the adipocyte extracellular matrix gene expression profile due to dietary intervention (VLCD-group);   change in the adipocyte extracellular matrix gene expression profile during Weight-stable period (VLCD-group);   change in the adipocyte extracellular matrix gene expression profile during follow-up period (VLCD-group);   change in the adipocyte extracellular matrix gene expression profile due to dietary intervention (LCD-group);   change in the adipocyte extracellular matrix gene expression profile during Weight-stable period (LCD-group);   change in the adipocyte extracellular matrix gene expression profile during follow-up period (LCD-group);   change in adipocyte stress proteins expression due to dietary intervention (VLCD-group);   change in adipocyte stress proteins expression during Weight-stable period (VLCD-group);   change in adipocyte stress proteins expression during follow-up period (VLCD-group);   change in adipocyte stress proteins expression due to dietary intervention (LCD-group);   change in adipocyte stress proteins expression during Weight-stable period (LCD-group);   change in adipocyte stress proteins expression during follow-up period (LCD-group)
12 Not yet recruiting SHARE Study 4: Financial Incentives for Weight Loss
Condition: Obesity
Interventions: Behavioral: Online Weight loss + incentives for behavior 3 months;   Behavioral: Online Weight loss + incentives for Weight loss at month 3;   Behavioral: Online Weight loss + Incentives for behavior 12 months;   Behavioral: Online Weight loss + Incentives for Weight loss 12 months
Outcome Measures: Weight change from initial assessment to the 3-month follow-up assessment measured on a digital scale to the nearest 0.1-kilogram;   Weight change from the initial assessment to the 12 month assessment measured on a digital scale to the nearest 0.1-kilogram;   Weight change from the 3 month assessment to the 12 month assessment measured on a digital scale to the nearest 0.1-kilogram
13 Recruiting Lay Health Coaches for Weight Loss: Peers Versus Mentors
Condition: Obesity
Interventions: Behavioral: Reduced Intensity Behavioral Weight Loss + Peer Health Coach;   Behavioral: Reduced Intensity Behavioral Weight Loss + Mentor Health Coach;   Behavioral: Reduced Intensity Behavioral Weight Loss
Outcome Measures: Weight change from the initial assessment to the 12-month assessment measured on a digital scale to the nearest 0.1-kilogram;   Direction of social comparison between participants and their Peer or Mentor Weight loss coach
14 Not yet recruiting Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors
Conditions: Endometrial Cancer;   Obesity
Interventions: Dietary Supplement: Dietary Intervention;   Other: Informational Material;   Other: Dietary Education;   Dietary Supplement: Weight Maintenance;   Other: Average score of Obesity and Weight-Loss Quality of Life Questionnaire
Outcome Measures: Mean Weight loss assessed with the digital scale;   Changes in levels of total cholesterol;   Changes in levels of markers of inflammation (C-reactive protein);   Changes in levels of glucose;   Number of drop-out participants;   Average percentage of positive urinary ketone tests as a marker of dietary adherence;   Number of Participant with reported side effects;   Changes in quality-of-life as assessed by the Obesity and Weight Loss Quality-of-Life Questionnaire;   Changes in levels of markers of inflammation (interleukin 6);   Changes in levels of markers of inflammation (tumor necrosis factor - alpha);   Changes in levels of markers of inflammation (leptin);   Changes in levels of LDL-cholesterol;   Changes in levels of HDL-cholesterol;   Changes in levels of triglycerides
15 Unknown Reducing Antipsychotic-Induced Weight Gain in Children With Metformin
Conditions: Obesity;   Weight Gain;   Psychotropic Induced Weight Gain
Intervention: Drug: Metformin
Outcome Measures: Change in Weight;   Weight trajectory based on length of intervention and factors that predict response to Metformin
16 Recruiting Personalized Management of Body Weight During Pregnancy
Condition: Weight Gain During Pregnancy
Intervention: Behavioral: SmartMoms
Outcome Measures: Proportion of pregnant women who gain more Weight during pregnancy than is recommended by the Institute of Medicine;   Relationship between Weight gain during pregnancy, the mother's physical activity and diet on the chance of the mother getting diabetes during pregnancy;   Relationship between Weight gain during pregnancy, the mother's physical activity and diet on the baby's Weight at birth;   Relationship between Weight gain during pregnancy, the mother's physical activity and diet on the mother and baby's body fatness;   Relationship between Weight gain during pregnancy, the mother's physical activity and diet on how much pregnancy Weight the mother keeps after she delivers her baby;   Relationship between Weight gain during pregnancy, the mother's physical activity and diet on how much the baby eats
17 Recruiting Ultrasound Characterization of Ovarian Morphology During Weight Loss in Women With Polycystic Ovary Syndrome (PCOS)
Conditions: Weight Loss;   Anovulation;   Amenorrhea;   Infertility
Intervention: Behavioral: Commercial diet
Outcome Measures: Ovulation during a Weight loss intervention in women with PCOS;   Endometrial development during a Weight loss intervention in women with PCOS;   Changes in metabolism and body composition during a Weight loss intervention in women with PCOS;   Changes in ovarian morphology, metabolism, and body composition in the six months after a Weight loss intervention in women with PCOS
18 Recruiting Progressive Weight Loss and Metabolic Health
Conditions: Insulin Resistance;   Obesity
Interventions: Behavioral: Weight maintenance;   Behavioral: Weight Loss
Outcome Measures: Insulin Sensitivity;   intra-hepatic triglyceride;   total cholesterol;   systolic blood pressure;   gut microflora;   brain structure;   brain function
19 Unknown Secondary Bypass Banding for Weight Regain or Weight Loss Failure After Lap. Gastric Bypass
Condition: Morbid Obesity
Intervention: Device: Secondary Bypass Banding (adjustable A.M.I. Soft Gastric Band)
Outcome Measure: Weight loss
20 Unknown Comparison of a Technology-based System and an In-person Behavioral Weight Loss Intervention in the Severely Obese
Condition: Obesity
Interventions: Behavioral: In-Person Weight loss;   Behavioral: FIT Weight loss;   Behavioral: FIT-BT Weight loss
Outcome Measures: Change in body Weight;   Change in body composition;   Change in moderate-to-vigorous intensity physical activity;   Change in dietary intake;   Completion of self-monitoring of eating behavior;   Frequency of self-monitoring of physical activity behavior

privacy policy